Titan Biotech Limited Press Release Sep 03 2026
Filed with BSE · · 1 page · English
Summary by 6ix AI
The Board of Directors recommended a final dividend subject to shareholder approval at the upcoming Annual General Meeting. Payment will occur after the Annual General Meeting, pending approval and tax deductions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Fixation Of Annual General Meeting Date, Record Date, Book Closure Date And E-Voting Date
- Corporate Action-Fixes Book Closure For 34Th Annual General Meeting Of The Company
- Corporate Action-Board recommends Bonus Issue
- Board Meeting Outcome for Outcome Of Board Meeting Dated September 3, 2026
- Titan Biotech Limited Press Release Aug 31 2026
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Sep 04 2026
- Reg. 34 (1) Annual Report.
- Notice Of Thirty- Fourth (34Th) Annual General Meeting
- Titan Biotech Limited Press Release Sep 05 2026
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech